“Severe PMS is just something women have to live with.”
Severe premenstrual symptoms that disrupt daily life, including PMDD, are recognized and treatable.
Severe PMS or PMDD is not a character flaw or an inevitable burden. It deserves diagnosis and a treatment plan that can be adjusted if the first option fails.
Track daily symptoms and cycle timing for at least two cycles, then bring the record to a clinician who can assess PMDD and alternative explanations.
Safety note: SSRIs can cause nausea, sleep changes and sexual side effects, and combined hormonal contraceptives are not suitable for everyone. Treatment choice should account for pregnancy plans, migraine with aura, clot risk, smoking, other medicines and mental-health history.
Talk to a healthcare professional if: premenstrual symptoms get in the way of work, school, relationships or your safety. If you have thoughts of harming yourself, get help right away.
Strong confidence because severe premenstrual disorders are recognized clinical conditions with guideline-supported treatments. A 2024 Cochrane review of 34 randomized trials found that SSRIs probably reduce PMS and PMDD symptoms, although adverse effects and individual response matter.
Severe premenstrual symptoms that disrupt daily life, including PMDD, are recognized and treatable. Effective options include SSRIs, and guidelines also support individualized hormonal, psychological and lifestyle approaches.
Diagnosis depends on a recurring cycle-linked pattern and meaningful impairment. Daily symptom ratings across at least two cycles can distinguish a premenstrual disorder from symptoms that are present throughout the month or another condition that worsens premenstrually.
- American College of Obstetricians and Gynecologists. Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7. Obstetrics & Gynecology. 2023;142(6):1516-1533. DOI: 10.1097/AOG.0000000000005426. PMID: 37973069
- Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews. 2024;(8):CD001396. DOI: 10.1002/14651858.CD001396.pub4. PMID: 39140320. PMCID: PMC11323276